Drug Manufacturers - General Industry Stocks
The Drug Manufacturers - General industry includes 17 US-listed companies on StockSifting — NYSE and NASDAQ stocks that sit within the broader Healthcare sector of the American equity market. A review of these businesses highlights recurring competitive themes such as Treatment, Treat, Healthcare, Patients, Under, which typically drive revenue growth, margin expansion, and capital allocation decisions across this industry. Names like Eli Lilly and Company, AbbVie Inc., Merck & Co., Inc., and AstraZeneca PLC show how companies in the Drug Manufacturers - General space compete through differentiated strategies including scale advantages, specialised IP, pricing power, distribution networks, and technology platforms. For US investors, this industry-level view is one of the most efficient ways to compare P/E ratios, ROCE, ROE, dividend yield, market cap, and 52-week trading ranges across true peers — companies that face the same macro drivers, regulatory environment, and end-market demand. Use the table below to rank all Drug Manufacturers - General stocks by any fundamental metric and identify which US-listed companies in this industry offer the best combination of quality, value, and growth for your portfolio.
About the Drug Manufacturers - General industry
This Drug Manufacturers - General industry page is designed for US investors who want a cleaner peer comparison set. Instead of screening unrelated stocks together, you can review businesses from the same industry, compare valuation and profitability, and move into individual company pages for deeper research.
17 Companies in Drug Manufacturers - General
Compare US-listed companies by price, P/E ratio, market cap, dividend yield, ROCE, ROE, and 52-week high-low range.
| S.No.↑ | Company Name↕ | Price↕ | P/E↕ | Market Cap↕ | Div Yield↕ | ROCE↕ | ROE↕ | 52 Week High↕ | 52 Week Low↕ |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly and Company | $1,131.42 | 42.48 | $1,073.64 B | 0.61% | 38.44% | 101.31% | $1,166.29 | $623.78 |
| 2 | AbbVie Inc. | $227.23 | 109.33 | $397.42 B | 3.08% | 22.16% | 95.59% | $244.81 | $181.73 |
| 3 | Merck & Co., Inc. | $120.79 | 33.35 | $298.02 B | 2.83% | 20.37% | 17.93% | $125.14 | $76.66 |
| 4 | AstraZeneca PLC | $185.95 | 27.26 | $281.02 B | 0.02% | — | 22.27% | $21,029.41 | $13,508.02 |
| 5 | Novartis AG | $149.16 | 19.84 | $211.48 B | 0.03% | 21.09% | 31.67% | $131 | $91.2 |
| 6 | Novo Nordisk A/S | $42.96 | 10.34 | $195.57 B | 0.04% | 39.01% | 66.36% | $533.4 | $224.25 |
| 7 | Amgen Inc. | $349.58 | 24.32 | $189.73 B | 2.92% | 13.95% | 89.41% | $391.29 | $267.83 |
| 8 | Gilead Sciences, Inc. | $129.16 | 17.58 | $162.06 B | 2.54% | 24.79% | 42.21% | $157.29 | $104.46 |
| 9 | Pfizer Inc. | $26.04 | 19.81 | $148.39 B | 6.7% | 10.17% | 8.37% | $28.75 | $23.08 |
| 10 | Bristol-Myers Squibb Company | $57.27 | 19.58 | $117.05 B | 4.45% | 20.6% | 41.64% | $62.89 | $42.52 |
| 11 | Biogen Inc. | $195.34 | 21.36 | $29.3 B | — | 9.46% | 7.54% | $205.97 | $121.05 |
| 12 | Organon & Co. | $13.36 | 14.26 | $3.51 B | 0.6% | 11.7% | 29.87% | $13.48 | $5.69 |
| 13 | Scilex Holding Company | $7 | — | $59.44 M | — | 55.67% | -130.91% | $34.27 | $4.2 |
| 14 | MIRA Pharmaceuticals, Inc. | $1 | — | $42.02 M | — | -100.98% | -140.83% | $2.45 | $0.9 |
| 15 | Nasus Pharma Ltd. | $2.93 | — | $27.84 M | — | -172.62% | -423.12% | $9.99 | $1.98 |
| 16 | Medicus Pharma Ltd. | $0.35 | — | $19.83 M | — | -27863.04% | -681.88% | $3.69 | $0.25 |
| 17 | Johnson & Johnson | — | — | — | — | — | — | — | — |